Literature DB >> 27421615

Maternal and perinatal outcomes after fresh versus frozen embryo transfer-what is the risk-benefit ratio?

Siladitya Bhattacharya1.   

Abstract

Fresh ET has been the conventional strategy in IVF, but there is a growing opinion suggesting that its maternal and perinatal outcomes can be enhanced by a policy of elective freezing of embryos, followed by transfer at a later date. Available studies suggest a number of improved maternal and perinatal outcomes after frozen ET, although there is also a suggestion of large for gestational age babies associated with this strategy. The observational nature of the available data limit our confidence in the results of available studies. A genuinely unbiased estimate of the advantages of a policy of elective ET can only be confirmed by a definitive randomized controlled trial with an adequate length of follow-up of the offspring.
Copyright © 2016 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Frozen embryo transfer; maternal; outcomes; perinatal

Mesh:

Year:  2016        PMID: 27421615     DOI: 10.1016/j.fertnstert.2016.06.038

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  12 in total

1.  [Pregnancy and obstetric outcomes of fresh embryo transfer versus frozen-thawed embryo transfer in women below 35 years of age].

Authors:  Ling Sun; Zhi-Heng Chen; Min-Na Yin; Yu Deng
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-07-20

2.  Elevated progesterone and its impact on birth weight after fresh embryo transfers.

Authors:  Yetunde Ibrahim; Miriam J Haviland; Michele R Hacker; Alan S Penzias; Kim L Thornton; Denny Sakkas
Journal:  J Assist Reprod Genet       Date:  2017-04-17       Impact factor: 3.412

3.  First trimester pregnancy ultrasound findings as a function of method of conception in an infertile population.

Authors:  Frauke von Versen-Höynck; Jenna S Petersen; Yueh-Yun Chi; Jing Liu; Valerie L Baker
Journal:  J Assist Reprod Genet       Date:  2018-01-29       Impact factor: 3.412

4.  Endometrial thickness is an independent risk factor of hypertensive disorders of pregnancy: a retrospective study of 13,458 patients in frozen-thawed embryo transfers.

Authors:  Meng Zhang; Jing Li; Xiao Fu; Yiting Zhang; Tao Zhang; Bingjie Wu; Xinyue Han; Shanshan Gao
Journal:  Reprod Biol Endocrinol       Date:  2022-06-28       Impact factor: 4.982

5.  Abnormal implantation after fresh and frozen in vitro fertilization cycles.

Authors:  Erica T Wang; Anupama S Q Kathiresan; Catherine Bresee; Naomi Greene; Carolyn Alexander; Margareta D Pisarska
Journal:  Fertil Steril       Date:  2017-04-19       Impact factor: 7.329

Review 6.  When Should We Freeze Embryos? Current Data for Fresh and Frozen Embryo Replacement IVF Cycles.

Authors:  Michail Kalinderis; Kallirhoe Kalinderi; Garima Srivastava; Roy Homburg
Journal:  Reprod Sci       Date:  2021-05-25       Impact factor: 2.924

7.  Factors associated with embryo splitting and clinical outcome of monozygotic twins in pregnancies after IVF and ICSI.

Authors:  A MacKenna; J E Schwarze; J Crosby; F Zegers-Hochschild
Journal:  Hum Reprod Open       Date:  2020-05-15

8.  Preimplantation genetic testing and frozen embryo transfer synergistically decrease very pre-term birth in patients undergoing in vitro fertilization with elective single embryo transfer.

Authors:  Luke Y Ying; Mark D Sanchez; James Baron; Ying Ying
Journal:  J Assist Reprod Genet       Date:  2021-07-01       Impact factor: 3.357

9.  Fresh versus frozen embryo transfer for full-term singleton birth: a retrospective cohort study.

Authors:  Junwei Zhang; Mingze Du; Zhe Li; Lulu Wang; Jijun Hu; Bei Zhao; Yingying Feng; Xiaolin Chen; Lijun Sun
Journal:  J Ovarian Res       Date:  2018-07-16       Impact factor: 4.234

Review 10.  The Future of Cryopreservation in Assisted Reproductive Technologies.

Authors:  Ernesto Bosch; Michel De Vos; Peter Humaidan
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-20       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.